Advancing age is the strongest risk factor for the development of neurodegenerative disorders such as Alzheimer disease (AD).
1 A common feature of these diseases is the age-associated accumulation of protein aggregates, including senile plaques comprised of amyloid-β (Aβ) 1-42 in AD, α-synuclein within Lewy bodies in Parkinson disease and Lewy body dementia, and hyperphosphorylated tau within neurofibrillary tangles in AD and chronic traumatic encephalopathy,
2 yet the upstream changes that render the aging brain vulnerable to the misaggregation of proteins remain unknown.